A comprehensive view of Takeda Pharmaceutical Co. Ltd.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Beauty & Personal Care Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Astellas Pharma, Eisai, Daiichi Sankyo and Takeda to collaborate in development of more environmentally friendly packaging for pharmaceutical products; potential solutions could include blister packs made of biomass-based plastic
Published: December 22, 2022 by PR Newswire
Kao Industrial, Takeda sign Thailand Dengue Prevention and Control memorandum of understanding; collaboration aims to cover all 50 districts in Bangkok and extend to other provinces nationwide to raise awareness about Dengue fever, increase prevention
Published: October 31, 2022 by Kao Corp.
MHRA raises concerns with switching between long-acting J&J, Novartis and Takeda drugs to treat attention-deficit/hyperactivity disorder
Published: October 11, 2022 by Indian Pharma Industry: Policies
Puma Biotechnology to license Japanese drug firm Takeda’s experimental oral drug alisertib used to treat breast and lung cancers in deal worth up to US$294.0M; Puma to be responsible for global development, commercialization of the drug
Published: September 22, 2022 by SeeNews Pharmaceuticals
Takeda’s injectable Takhzyro lanadelumab-flyo now available in US in single-dose prefilled syringes to prevent attacks of hereditary angioedema in adult, pediatric patients 12 years of age and older; HAE affects 1 in 50,000 people worldwide
Published: April 25, 2022 by ENP Newswire

Ask us about our Beauty & Personal Care market view

Trending Chart

Interactive chart with headline count